Bank of Montreal’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.84M Sell
30,523
-2,182
-7% -$274K ﹤0.01% 1171
2025
Q1
$3.62M Sell
32,705
-2,389
-7% -$264K ﹤0.01% 1129
2024
Q4
$4.79M Sell
35,094
-20,150
-36% -$2.75M ﹤0.01% 1095
2024
Q3
$6.36M Buy
55,244
+15,893
+40% +$1.83M ﹤0.01% 1108
2024
Q2
$5.42M Buy
39,351
+2,102
+6% +$289K ﹤0.01% 1113
2024
Q1
$5.14M Sell
37,249
-8,414
-18% -$1.16M ﹤0.01% 1090
2023
Q4
$6.08M Sell
45,663
-108,729
-70% -$14.5M ﹤0.01% 1035
2023
Q3
$17.6M Sell
154,392
-127,769
-45% -$14.5M 0.01% 689
2023
Q2
$27.7M Buy
282,161
+215,023
+320% +$21.1M 0.01% 557
2023
Q1
$6.81M Buy
67,138
+8,038
+14% +$816K ﹤0.01% 999
2022
Q4
$7.1M Buy
59,100
+63
+0.1% +$7.57K ﹤0.01% 972
2022
Q3
$6.3K Buy
59,037
+48,143
+442% +$5.14K ﹤0.01% 1039
2022
Q2
$1.07K Sell
10,894
-71,849
-87% -$7.05K ﹤0.01% 1922
2022
Q1
$7.67M Sell
82,743
-28,078
-25% -$2.6M ﹤0.01% 1045
2021
Q4
$9.41M Sell
110,821
-636,419
-85% -$54M 0.01% 949
2021
Q3
$71.1M Buy
747,240
+385,781
+107% +$36.7M 0.03% 406
2021
Q2
$36.2M Buy
361,459
+8,024
+2% +$804K 0.02% 595
2021
Q1
$32.8M Buy
353,435
+84,197
+31% +$7.8M 0.02% 491
2020
Q4
$29.7M Buy
269,238
+141,351
+111% +$15.6M 0.02% 514
2020
Q3
$12.4M Sell
127,887
-14,221
-10% -$1.38M 0.01% 692
2020
Q2
$18.7M Buy
142,108
+107,945
+316% +$14.2M 0.02% 563
2020
Q1
$2.95M Sell
34,163
-342
-1% -$29.5K ﹤0.01% 1136
2019
Q4
$3.71M Sell
34,505
-29,694
-46% -$3.19M ﹤0.01% 1315
2019
Q3
$5.79M Buy
64,199
+8,227
+15% +$741K 0.01% 982
2019
Q2
$4.73M Buy
55,972
+35,360
+172% +$2.99M ﹤0.01% 1072
2019
Q1
$1.82M Sell
20,612
-43,249
-68% -$3.81M ﹤0.01% 1510
2018
Q4
$4.56M Buy
63,861
+991
+2% +$70.8K ﹤0.01% 1020
2018
Q3
$7.73M Buy
62,870
+32,855
+109% +$4.04M 0.01% 932
2018
Q2
$2.95M Buy
30,015
+186
+0.6% +$18.3K ﹤0.01% 1313
2018
Q1
$2.47M Buy
29,829
+19,062
+177% +$1.58M ﹤0.01% 1379
2017
Q4
$835K Buy
10,767
+8,837
+458% +$685K ﹤0.01% 1854
2017
Q3
$119K Buy
1,930
+883
+84% +$54.4K ﹤0.01% 2674
2017
Q2
$48K Sell
1,047
-71
-6% -$3.26K ﹤0.01% 2938
2017
Q1
$48K Sell
1,118
-323
-22% -$13.9K ﹤0.01% 2843
2016
Q4
$67K Buy
1,441
+721
+100% +$33.5K ﹤0.01% 2722
2016
Q3
$36K Hold
720
﹤0.01% 2893
2016
Q2
$33K Sell
720
-814
-53% -$37.3K ﹤0.01% 2931
2016
Q1
$61K Buy
1,534
+79
+5% +$3.14K ﹤0.01% 2755
2015
Q4
$82K Buy
1,455
+592
+69% +$33.4K ﹤0.01% 2666
2015
Q3
$34K Buy
+863
New +$34K ﹤0.01% 2825
2015
Q2
Sell
-447,200
Closed -$17.8M 3767
2015
Q1
$17.8M Buy
+447,200
New +$17.8M 0.02% 538
2014
Q3
Sell
-1,860
Closed -$28K 3760
2014
Q2
$28K Buy
+1,860
New +$28K ﹤0.01% 3037